The US company has acquired exclusive ownership of the patent from a global pharmaceutical company and expects to make the product available by early 2020
Phillips-Medisize has acquired exclusive ownership from a global pharmaceutical company of patents supporting an innovative mini-tablet dispenser. The product accommodates the varied and customised oral dispensing needs of patients.
"Through its unique working principle, the mini-tablet dispenser will be valuable in paediatrics, geriatrics and oncology where patients often require highly flexible oral dosing based on age, weight and other variables," said Matt Jennings, CEO and President, Phillips-Medisize. "Furthermore, in smaller patient populations the option to flexibly count to combine incremental mini-tablet doses offers an advantage over-preparing multiple fixed oral tablet dose strengths."
The mini-tablet dispenser differentiates itself from most available systems that predominantly rely on volumetric measuring principles. With the assistance of this dispenser mounted on top of a standard tablet bottle, a patient or caregiver will be able to count and dispense mini-tablets in predetermined amounts from one to twenty tablets, and it supports tablets of approximately 2x2 mm to 2.3x2.3 mm dimensions.
The mini-tablet dispenser enables the user to visually confirm the measured tablet count number before dispensing and is designed to minimise damage or crushing of the mini-tablets during dispensing.
Phillips-Medisize has begun industrialisation preparations aiming to make the dispenser available to an array of pharmaceutical companies globally in early 2020.